30 results
424B3
h81ez96v9arobwaxfa
4 Apr 23
Prospectus supplement
4:57pm
POS AM
94plao7pixsrsga5kkq
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-99.1
i2j70p4it
17 Nov 22
Inhibikase Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity
4:30pm
PRE 14A
2m22mie6j5crkz
21 Apr 22
Preliminary proxy
4:33pm
S-3
dv5rc2kx2z4rndqug
7 Feb 22
Shelf registration
12:00am
424B4
b10 64ngmi2
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
3uin l7b5o0tsn0
2 Jun 21
Draft registration statement
12:00am
DEFA14A
whh0gh
30 Apr 21
Additional proxy soliciting materials
5:21pm